FIMM Meta User Policy

FIMM metabolomics core facility is open to both academic and commercial users nationally and internationally on primary access model being first come, first served.


The use of HiLIFE LSRIs should be mentioned in the acknowledgement section of publications, for example with the sentence “The facilities and expertise of FIMM Metabolomics, supported by HiLIFE is gratefully acknowledged”.



When LSRI PI or personnel provides substantial intellectual input to the project, they should be included as authors according to established guideline of the Finnish national board on research integrity.



More information on Helsinki Institute of Life Science research infrastructures  (HiLIFE LSRI) can be found on this website.

Our research is funded by: